bullish
IPCA Labs: 1QFY19 Result - International Sales Decline but EBITDA Margins Improve
276 Views21 Aug 2018 20:00
Ipca Laboratories (IPCA IN) reported revenue growth of 20% YoY at Rs. 8,427 mn, EBITDA at Rs. 1,140 mn and PAT at Rs. 655 mn in 1QFY19 led by low...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Trivikram Consultants
Picking Long Term Multi-bagger stocks
Price Chart(Sign Up to Access)
- IPCA Laboratories- 2QFY19 Results – Growing While Awaiting USFDA Approvals29 Nov 2018
- IPCA Labs: 1QFY19 Result - International Sales Decline but EBITDA Margins Improve21 Aug 2018
- IPCA: Annual Report FY18: Normal Service to Resume01 Aug 2018
- IPCA 4QFY18 Results Confirm Recovery Story05 Jun 2018
- IPCA Labs- The Revival Story13 Apr 2018
x